Iconovo’s rights issue is registered – conversion of BTA into shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG,…

Iconovo’s development of intranasal GLP-1 for a more convenient treatment of obesity is making significant progress

Iconovo AB (publ), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, today announce that the development of spray-dried formulations of intranasal GLP-1 is making significant progress. Iconovo has obtained several batches of formulations from its partner Lonza and begun feasibility studies in ICOone Nasal®. Data shows impressive and consistent capabilities suitable for nasal inhalation.

Iconovo’s nomination committee proposes the election of Christer Fåhraeus as new board member

Iconovo AB today announces that the company's Nomination Committee has decided to revise its proposal for the annual general meeting to be held today 9 June 2025 by proposing that Christer Fåhraeus is elected as a new member of the Board of Directors in addition to the Board members previously proposed. The background for the revision is that the Nomination Committee has been informed that FSG Fund II AB ("FSG") has participated in the recently completed rights issue and that FSG, after final registration of the rights issue, will hold approximately 15.5 per cent of the shares and votes in Iconovo.

Iconovo announces final outcome in the rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR IN ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, REQUIRE REGISTRATION OR ANY OTHER MEASURES.

Iconovo announces preliminary outcome of rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR IN ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, REQUIRE REGISTRATION OR ANY OTHER MEASURES.

Last day of trading in subscription rights in Iconovo

Today, 27 May 2025, is the last day of trading in the subscription rights issued in conjunction with Iconovo AB (publ)'s (“Iconovo” or the “Company”) rights issue of shares with pre-emption rights for existing shareholders resolved by the Board of Directors on 24 April 2025, and approved by the Extraordinary General Meeting on 12 May 2025 (the “Rights Issue”). Subscription rights that are not sold by today, 27 May 2025, or exercised for subscription of shares no later than 2 June 2025, will expire without value.

Iconovo publishes information document regarding rights issue of shares and invites to investor presentation

Iconovo AB ("Iconovo" or the "Company") publishes an information document (the "Information Document") relating to the rights issue of shares of approximately 36.6 MSEK before deduction of issue costs (the "Rights Issue"), which was resolved by the Board of Directors on 24 April 2025 and approved by the Extraordinary General Meeting on 12 May 2025. In connection with the Rights Issue, the Company also invites to an investor presentation on 21 May 2025.

Correction: ICONOVO AB PUBLISHES THE ANNUAL REPORT 2024 IN ENGLISH

Wrong annual report initially attached to this press release; hereby corrected. The abbreviated annual report 2024 in English is attached to this press…

ICONOVO AB PUBLISHES THE ANNUAL REPORT 2024 IN ENGLISH

The abbreviated annual report 2024 in English is attached to this press release and is now available on the company's website, www.iconovo.se. ContactsJohan Wäborg,…

Iconovo’s nomination committee proposes election of two new board members

Iconovo AB today announces that the company’s Nomination Committee proposes that Erik Westerlund and Andreas Engström are elected as new members of the Board of Directors at the annual general meeting on 9 June 2025. The Nomination Committee further proposes re-election of Berndt Axelsson, Mats Johansson, Orest Lastow and Carl Lindgren as members of the Board of Directors. The current board members Agneta Walhagen and Erik Ekman have declined re-election.